Press Releases

Nicholas Piramal Q3 Net at Rs 21 crore

Nicholas Piramal (NPIL) has posted a net profit of Rs 219.6 crore. The figures are not strictly comparable with the corresponding period of the previous year since the latter does not include the numbers of pharmaceutical business that NPIL acquired from ICI in March'02.

On a comparable basis, i.e. without including sales of the ICI pharma business, sales in the first nine months of the year have grown 12.5% from the corresponding period of the previous year. NPIL's net profit in the first nine months of the year stood at Rs 78.5 crore on net sales of Rs 697 crore.